After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...